Profit from Process efficiencies through Industry 4.0 – Pharmaceutical Industry

The dawn of Pharma 4.0 has brought about a precedence of smart manufacturing with AI, IoT and automation. Such technologies are increasingly prevalent and have become crucial to the continued success and competitiveness of today’s global manufacturers. How effectively these technologies are deployed on the journey from data collection to the hallmark digital maturity of Industry 4.0 will define the next generation of pharmaceutical manufacturing.

As Indian Pharma industry stands on the cusp of two definite opportunities. The upsurge in demand for drugs usage for Cancer, Hypertension, Diabetes etc. (Between 35% to 70% Jump in certain areas) and to exploit the vacuum created by US sanctioned markets which are increasing and for Pharma they are looking towards Indian companies.

Hence the Industry is to face ever increasing competition, higher production requirements, and a stricter regulatory environment which will put a huge pressure on pharma manufacturers to optimise production. The Industry needs to harmonize its practices and guides and the launching easier and stronger adherence to FDA current good manufacturing practices – the cGMP; for the coming 21st century.

The pharmaceutical industry is creating modular, continuous and scalable processes and manufacturing environments to meet cost and quality challenges head on.

Join our strategic and Insightful Roundtable that would virtually bring senior professionals across the pharmaceutical industry to explore the best strategies & practices on How the emerging technologies that characterize Industry 4.0—from connectivity to advanced analytics and automation—have the potential to revolutionize every element of pharma-manufacturing labs.